MJFF Partners with Verily to Use Data Collection Watch in PPMI Study to Advance Parkinson’s Research

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Verily Life Sciences are collaborating to collect data on movement, physiological, and environmental measures in Parkinson’s patients for the MJFF-led Parkinson’s Progression Markers Initiative (PPMI). More than 800 PPMI participants will be outfitted with Verily’s investigational Study Watch, a multi-sensor…

Six Parkinson’s Community Leaders Receive Advocacy Awards

Six Parkinson’s community leaders have received 2018 Advocacy Awards for their efforts to push policies that benefit patients, families, caregivers and others. Two of the winners were recognized for their role in establishing the Accelerating Medicines Partnership Program, which in January 2018 announced a new Parkinson’s disease focus. Representatives…

New Parkinson’s Collaboration Is Exactly What’s Needed, Editorial Says

So much Parkinson’s-related biomarker information has been collected under various research projects that sorting through it for additional clues to the disease poses a challenge to scientists. The scope of the information makes a collaborative research effort paramount — and a U.S. government-sponsored initiative is meeting that need, according to…